Caixin News on September 15th (Editor: Li Chen) This week (September 9-September 13), the A-share listed company's buyback trend continued. According to Caixin incomplete statistics, including WuXi Apptec, Jutze Intelligence Technology, Westone Technology, ZJAMP Group, Jiajiayue Group, Double Medical Technology, Weijaichuangxin, Guizhou Sanli Pharmaceutical Co., Ltd., Victory Giant Technology, Xidi New Energy, and Guangdong DFP New Material Group, 11 listed companies announced their intention to repurchase company shares, and the maximum buyback amount reaches 0.1 billion yuan or more. The specific situation is as shown in the following figure:

Among them, WuXi Apptec, a leading CRO with a total market value of over 110 billion yuan, announced on Tuesday evening the publication of the repurchase report for the third time in 2024 by centralized auction to repurchase A-share stocks. The total repurchase funds for this time are 1 billion yuan, and the source of funds for repurchasing shares is from the company's own funds. The repurchase price of shares shall not exceed 61.02 yuan/share (inclusive). The shares repurchased this time are all intended to be cancelled and reduce the registered capital. It is worth noting that this is the third 1 billion yuan-level A-share cancellation repurchase plan by WuXi Apptec in the year. Prior to this, WuXi Apptec completed the previous two repurchase plans on February 5 and May 22, repurchasing a total of 2 billion yuan of A-share stocks. On Wednesday, WuXi Apptec announced the progress of the share repurchase, repurchasing 0.5223 million shares for the first time.

In a research report released by CMBI and others on September 12, it is expected that WuXi Apptec's revenue in 2024 will be 38.56 billion yuan. WuXi Apptec's main business is concentrated in pharmaceutical CRDMO services, estimated to be the world's largest pharmaceutical CRDMO supplier. From the perspective of revenue scale, WuXi Apptec's revenue volume far exceeds that of other overseas competitors. Its pharmaceutical CRMO business is mainly based on API, with a small proportion of preparations, and there are also production facilities in Switzerland. In the secondary market, data from Choice shows that WuXi Apptec's cumulative maximum price drop from the January peak to date reaches 50.55%.

Jutze Intelligence Technology, whose main business is the research, development, production, and sale of intelligent equipment and components, announced on September 9 that the company plans to repurchase company shares in the amount of 0.2 billion to 0.4 billion yuan, for employee stock ownership plans, stock-based incentives, or for the conversion of convertible bonds issued by listed companies into stocks. The repurchase price shall not exceed 20.8 yuan/share. On September 13, Jutze Intelligence Technology disclosed an investor relationship activity record, indicating that the company plans to continuously reduce costs and enhance efficiency for existing machine vision equipment products through the introduction of AI algorithms and structural design optimizations, actively deploying overseas service points. Jutze Intelligence Technology has already established subsidiaries, branches, or offices in Singapore, Malaysia, the Czech Republic, Vietnam, Japan, and Mexico, and has obtained certification from some customers for the cable assembly business, enabling bulk shipments. Jutze Intelligence Technology has obtained 88 software copyrights and 136 patents, integrating AI algorithms with traditional algorithms, launching semiconductor AOI, using deep fusion technology to achieve 3D imaging with an optical resolution of 1um, to meet the needs of high-resolution 3D detection in semiconductors.

In addition to WuXi Apptec, according to Caixin incomplete statistics, this week (September 9-September 13), there are three listed companies, Westone Technology, Xidi New Energy, and Guangdong DFP New Material Group, that announced their intention to repurchase company shares and use them to reduce the company's registered capital. Westone Technology, which focuses on the research, development, manufacture, sales, and service of surgical medical devices, announced on September 13 its intention to repurchase shares in the amount of 0.15 billion to 0.3 billion yuan for cancellation, with a repurchase price not exceeding 80 yuan/share. In a research report released by East Money Information analyst He Wei on September 3, Westone Technology, as a domestic leader in surgical power devices, is experiencing rapid growth in consumables under the background of the gradual popularization of disposable consumables, with breast surgery products driving import substitution and further strengthening of R&D investment and channel construction, a large-scale launch of new products such as endoscopes and energy surgical devices is imminent.

The main business is the research and development, design, production, and sales of electrical connection products. On September 12th, Xidian announced that the company plans to repurchase company shares in the range of 50 million yuan to 0.1 billion yuan, for the purpose of cancellation and reduction of registered capital. The repurchase price does not exceed 40 yuan per share. Han Chen and others of Southwest Securities stated in a research report released on August 28th that the company is a leading domestic enterprise in the battery connection system, with unique hot pressing technology and competitive advantages in self-developed equipment. Analysts predict that the revenue of Xidian will be 2.45 billion yuan, 3.37 billion yuan, and 4.29 billion yuan in 2024-2026, with the expected year-on-year growth rates of net income attributable to the mother at 31.5%, 42.4%, and 27.9% over the next three years.

The main business of Dongfeng Group is the research, design, production, and sale of new energy new materials, Class I pharmaceutical packaging materials, and printing and packaging products. On September 9th, Dongfeng Group announced a plan to repurchase shares in the range of 50 million to 0.1 billion yuan, all of which will be used for the cancellation and reduction of the company's registered capital. The repurchase price is not to exceed 3.93 yuan per share (inclusive). On September 5th, Dongfeng Group issued a risk alert, stating that the company is engaged in the layout of semi-solid/state-of-the-art battery separators, membranes, and coating processes, and other related battery materials. It has been working on the development of multiple products, in conjunction with partners and downstream research on semi-solid separators and full solid-state membranes, but these related business activities are currently in the testing and sampling phase.